We are international
• videos TEXT SIZE   

Best of Ash 2013: What Patients Need to Know
Join IMF Chairman Brian G.M. Durie, MD, in a teleconference and Q&A on January 16 7pm ET/ 4pm PT as he highlights key information he has gleaned from over 800 myeloma abstracts presented at the 2013 annual meeting of the American Society of Hematology (ASH) that will have the biggest impact on myeloma patients, now and in the future.
Myeloma Updates 2013 Post ASCO/EHA/IMWG
Learn more about current trends in myeloma treatment and research with this update from three major medical meetings held in June 2013. Dr. Brian G.M. Durie will explain what’s new and exciting from the American Society of Clinical Oncology, the European Hematology Association, and the International Myeloma Working Group Summit

Health Reform and You: The ABC’s of the ACA for Private Health Insurance
Cancer patients and family members who want to learn about health care reform and how it will affect them, and in particular uninsured or under-insured individuals, and people interested in purchasing individual or small group health insurance through the newly created health insurance marketplaces.
What’s NEW with Novel Therapies?
With Dr. Brian Durie and Dr. Sagar Lonial
Teleconference originally aired on February 21, 2013

Best of ASH 2012 Teleconference:
What Patients Need to Know
Recorded January 17, 2013
with Dr. Brian G. M. Durie
Living Well with Multiple Myeloma Teleconferences
The IMF’s Living Well with Myeloma quarterly teleconference series is designed to cover all the important and most up to date information regarding multiple myeloma.

Nurse Leadership Board Teleconferences
Myeloma Manager™ Webinar Replay
If you missed the Webinar about the IMF's Myeloma Manager™ Personal Care Assistant™, we have a replay of our last Webinar, held on January 28, 2009, with everything you need to know about this incredible tool for tracking lab results, treatment regimens, and so much more.

Teleconference: Myeloma Updates 2012
280 patients, family members, caregivers and healthcare professionals participated in this teleconference. Listen to an audio recording and view the slides.
The Emerging Role of Kyprolis in the Treatment Paradigm
The IMF's Dr. Brian G.M Durie and Dr. Tom Martin of the University of California San Francisco discuss the emerging role of Kyprolis in the treatment paradigm.

The Importance of Clinical Trial Participation - A teleconference with Dr. Brian G. M. Durie
September 8,2011
Dr. Durie is National Director for Hematologic Malignancies for Aptium Oncology and Specialist in Multiple Myeloma and Related Disorders for Cedars-Sinai Outpatient Cancer Center in Los Angeles, CA
IMF Teleconference Archive